Konduri N, Lebega O. Analysis of medicines expenditure in ukraine: Implications for rational selection. E9 Short oral presentation, Part 2a (Practice & Education) at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016, Buenos Aires, Argentina. August 30, 2016.
Governments should not have to “break the bank” while working to achieve universal access to quality-assured and affordable essential medicines and vaccines for all, SIAPS Principal Technical Advisor Niranjan Konduri wrote in a Devex op-ed this week. Reacting to the WHO’s first global report on diabetes, released on April 6, Konduri identified inefficient government spending on pharmaceutical commodities as … Read more
In Ukraine in recent years, failed rounds of centralized public tenders for pharmaceuticals and blockage of public funds in antimonopoly litigations were regarded as a harbinger of the impending crisis in the public health sector. The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program was requested to step in and provide technical assistance … Read more
When doctors and patients fail to adhere to proper standards of treatment, it results in a higher disease burden, including greater financial costs, mortality, and morbidity. In Ukraine, the need to encourage better adherence to standard treatment guidelines became clear in 2011, when a study by SIAPS Program’s predecessor, the Strengthening Pharmaceutical Systems (SPS) Program, … Read more
At the 38th Annual Meeting of Representatives of National Pharmacovigilance Centres participating in the WHO Programme for International Drug Monitoring, held in New Delhi, India from 4-6 November, Olena Matvieieva from Ukraine’s Ministry of Health (MOH) presented the ways in which SIAPS and the MOH are working to improve the methodology and systems for passive … Read more
Ukraine has the second-highest burden of TB in the European region. According to the Ukraine’s Ministry of Health, TB is the leading cause of death from infectious diseases in the country. Ukraine’s efforts at TB control use a mix of standardized approaches, including Stop TB strategies, as well as directly observed therapy short-course (DOTS) guidelines … Read more
Pharmaceuticals may constitute as much as 40% of the health care budget in low and middle-income countries, yet large portions of the population may lack access to even the most essential medicines. The limited public sector funds are frequently spent on ineffective or unnecessary medications. An analysis of past spending patterns on procurement of medicines … Read more
On October 16, SIAPS Program officially transferred administration of e-TB manager, a web-based TB information system, to the Ukrainian Ministry of Health (MoH). e-TB Manager was piloted in six Ukrainian oblasts in 2010 under SIAPS Program’s predecessor, the Strengthening Pharmaceutical Systems (SPS) Program, before a nationwide roll-out began in 2012. e-TB Manager is now an official information … Read more
Medicine prices are a contentious issue, with many products arguably unaffordable, even in developed countries, where, on average, approximately 10% of the health budget is spent on medicines. But in low- and middle-income countries, that figure is usually substantially higher, reflecting both limited resources and generally inefficient public health systems. Given that a sizable proportion … Read more
The introduction of framework agreements for the 2015 public health care procurements in the Poltava and Dnipropetrovsk oblasts of Ukraine reduces the risk of stock-out and helps employees more efficiently use their time by creating more flexible, shorter procurement procedures, while decreasing the opportunity for corruption. These framework agreements, the first to be used for … Read more
